BCRX

BioCryst Pharmaceuticals Inc
$8.57 -3.82%

Recent alerts on BCRX

All signals →
Insider trade Sale by McKee Amy E
13d ago
News Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder
14d ago
News BioCryst (BCRX) Q2 Revenue Jumps 50%
14d ago
News Why BioCryst Pharmaceuticals Stock Tumbled by 10% Today
14d ago
Short volume Short volume 66% of volume (3.2σ)
18d ago
Insider trade Sale by Theresa Heggie
70d ago
Insider trade Sale by Alane P Barnes (Chief Legal Officer)
76d ago
News BioCryst gains amid takeover speculation
78d ago
News BioCryst outlines $625M–$645M 2026 ORLADEYO revenue target as HAE pipeline advances
96d ago
News Ford EV Business Took $19.5 Billion Write-Down, Pivoting to Gas-Powered Cars
104d ago
News BioCryst Pharmaceuticals reports prelim 2025 ORLADEYO revenue, provides 2026 guidance
141d ago
News BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
153d ago
News BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate'
153d ago
News BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting
153d ago
News Cycle Pharmaceuticals to Acquire Applied Therapeutics
156d ago
News Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
160d ago
News Cycle Pharmaceuticals to Acquire Applied Therapeutics
169d ago
News Cycle Pharmaceuticals to Acquire Applied Therapeutics
169d ago
News Cycle Pharmaceuticals to Acquire Applied Therapeutics
169d ago
News Cycle Pharmaceuticals to Acquire Applied Therapeutics
169d ago
News Cycle Pharmaceuticals to Acquire Applied Therapeutics
170d ago
News Cycle Pharmaceuticals to Acquire Applied Therapeutics
170d ago
News Cycle Pharmaceuticals to Acquire Applied Therapeutics
171d ago

Get push alerts for BCRX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS